{"title":"原住民口腔癌和癌前病变的流行率和发病率:系统性审查协议。","authors":"Swati Sapna, Praneetha Jain, Amrit Sharma, Rhythm Hora, Harshul Sharma, Vineetha Karuveettil","doi":"10.11124/JBIES-23-00207","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This review will determine the prevalence and incidence of oral cancer and pre-cancerous lesions in indigenous populations.</p><p><strong>Introduction: </strong>There are approximately 476 million indigenous individuals worldwide. Oral cancer affected over 350,000 people globally in 2018, with approximately 80% of cases occurring in the indigenous population. Moreover, the incidence of pre-cancerous lesions is high in this population, accounting for 48.3%. Limited evidence exists regarding the burden of oral cancer among indigenous populations despite research on oral health disparities in this group.</p><p><strong>Inclusion criteria: </strong>Studies on the burden of oral cancer and pre-cancerous lesions in indigenous groups, considering rates, ratios (prevalence or mortality), or survival proportions, will be considered for inclusion. There will be no limitations on study design, language, age, gender, or geography. We will exclude studies that only identify, diagnose, or screen oral cancer and pre-cancerous lesions without mentioning prevalence and incidence.</p><p><strong>Methods: </strong>This review will follow the JBI methodology for systematic reviews of prevalence and incidence. Databases to be searched will include MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), Cochrane Central Register of Controlled Trials, Scopus, and Dentistry and Oral Sciences Source (EBSCOhost). ProQuest Dissertations and Theses, OAIster, International Association for Dental Research conference abstracts, Google Scholar, government reports, and cancer registry reports will also be screened for unpublished studies. Two reviewers will independently screen articles, and data will be extracted using a customized form. Narrative data synthesis will be conducted and, where appropriate, meta-analysis will be performed. Methodological quality will be assessed using JBI's critical appraisal tool for prevalence studies.</p><p><strong>Review registration: </strong>PROSPERO CRD42023402858.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":"1177-1186"},"PeriodicalIF":1.5000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence and incidence of oral cancer and pre-cancerous lesions in indigenous populations: a systematic review protocol.\",\"authors\":\"Swati Sapna, Praneetha Jain, Amrit Sharma, Rhythm Hora, Harshul Sharma, Vineetha Karuveettil\",\"doi\":\"10.11124/JBIES-23-00207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This review will determine the prevalence and incidence of oral cancer and pre-cancerous lesions in indigenous populations.</p><p><strong>Introduction: </strong>There are approximately 476 million indigenous individuals worldwide. Oral cancer affected over 350,000 people globally in 2018, with approximately 80% of cases occurring in the indigenous population. Moreover, the incidence of pre-cancerous lesions is high in this population, accounting for 48.3%. Limited evidence exists regarding the burden of oral cancer among indigenous populations despite research on oral health disparities in this group.</p><p><strong>Inclusion criteria: </strong>Studies on the burden of oral cancer and pre-cancerous lesions in indigenous groups, considering rates, ratios (prevalence or mortality), or survival proportions, will be considered for inclusion. There will be no limitations on study design, language, age, gender, or geography. We will exclude studies that only identify, diagnose, or screen oral cancer and pre-cancerous lesions without mentioning prevalence and incidence.</p><p><strong>Methods: </strong>This review will follow the JBI methodology for systematic reviews of prevalence and incidence. Databases to be searched will include MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), Cochrane Central Register of Controlled Trials, Scopus, and Dentistry and Oral Sciences Source (EBSCOhost). ProQuest Dissertations and Theses, OAIster, International Association for Dental Research conference abstracts, Google Scholar, government reports, and cancer registry reports will also be screened for unpublished studies. Two reviewers will independently screen articles, and data will be extracted using a customized form. Narrative data synthesis will be conducted and, where appropriate, meta-analysis will be performed. Methodological quality will be assessed using JBI's critical appraisal tool for prevalence studies.</p><p><strong>Review registration: </strong>PROSPERO CRD42023402858.</p>\",\"PeriodicalId\":36399,\"journal\":{\"name\":\"JBI evidence synthesis\",\"volume\":\" \",\"pages\":\"1177-1186\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JBI evidence synthesis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11124/JBIES-23-00207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBI evidence synthesis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11124/JBIES-23-00207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
目的:本综述将确定土著人口中口腔癌和癌前病变的流行率和发病率:本综述将确定口腔癌和癌前病变在土著居民中的流行率和发病率:全球约有 4.76 亿原住民。2018 年,全球有超过 35 万人罹患口腔癌,其中约 80% 的病例发生在原住民人群中。此外,该人群的癌前病变发病率很高,占 48.3%。尽管对原住民口腔健康差异进行了研究,但有关原住民口腔癌负担的证据有限:纳入标准包括有关土著群体口腔癌和癌前病变负担的研究,考虑比率、比例(患病率或死亡率)或存活比例。我们将检索从开始到现在的数据库,对研究设计、语言、年龄、性别或地域不做限制。我们将排除仅识别、诊断或筛查口腔癌和癌前病变而未提及患病率和发病率的研究:本综述将遵循 JBI 对流行率和发病率进行系统综述的方法。将检索的数据库包括 MEDLINE (Ovid)、Embase (Ovid)、CINAHL (EBSCOhost)、Cochrane Central Register of Controlled Trials、Scopus 以及 Dentistry and Oral Sciences Source (EBSCOhost)。还将对 ProQuest Dissertations and Theses、OAIster、国际牙科研究协会会议摘要、Google Scholar、政府报告和癌症登记报告等未发表的研究进行筛选。两名审稿人将独立筛选文章,并使用定制表格提取数据。将进行叙述性数据综合,并酌情使用 JBI SUMARI 进行荟萃分析。方法学质量将使用 JBI 的流行病学研究关键评估工具进行评估:综述注册编号:PREMCORD42023402858。
Prevalence and incidence of oral cancer and pre-cancerous lesions in indigenous populations: a systematic review protocol.
Objective: This review will determine the prevalence and incidence of oral cancer and pre-cancerous lesions in indigenous populations.
Introduction: There are approximately 476 million indigenous individuals worldwide. Oral cancer affected over 350,000 people globally in 2018, with approximately 80% of cases occurring in the indigenous population. Moreover, the incidence of pre-cancerous lesions is high in this population, accounting for 48.3%. Limited evidence exists regarding the burden of oral cancer among indigenous populations despite research on oral health disparities in this group.
Inclusion criteria: Studies on the burden of oral cancer and pre-cancerous lesions in indigenous groups, considering rates, ratios (prevalence or mortality), or survival proportions, will be considered for inclusion. There will be no limitations on study design, language, age, gender, or geography. We will exclude studies that only identify, diagnose, or screen oral cancer and pre-cancerous lesions without mentioning prevalence and incidence.
Methods: This review will follow the JBI methodology for systematic reviews of prevalence and incidence. Databases to be searched will include MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), Cochrane Central Register of Controlled Trials, Scopus, and Dentistry and Oral Sciences Source (EBSCOhost). ProQuest Dissertations and Theses, OAIster, International Association for Dental Research conference abstracts, Google Scholar, government reports, and cancer registry reports will also be screened for unpublished studies. Two reviewers will independently screen articles, and data will be extracted using a customized form. Narrative data synthesis will be conducted and, where appropriate, meta-analysis will be performed. Methodological quality will be assessed using JBI's critical appraisal tool for prevalence studies.